Our department is looking for a software solution to support analysis and reporting of somatic cancer variants (currently panels, but eventually exomes). It looks like most of the currently available reporting software (Cartagenia, Next Code) is designed to support germline analysis (rare disease analysis). We would be interested in any software packages that are available to specifically support somatic cancer variant analysis. Know of any?
-
-
Gerald -- I work at GenomOncology. We offer a Clinical Workbench, installed within your firewall, where the input is the BAM/VCF and QC files to enable professional interpretation (in a high-assurance fully traceable and audit-able manner) and generate a clinically actionable report in less than 20 minutes from start to finish. The report is template driven and 100% customizable to your labs needs.
Vanderbilt’s MyCancerGenome, plus FDA, NCCN and ACSO guidelines, drive the clinical interpretation and also allows the lab to add relevant Clinical Trials and content. We have an exclusive license for MyCancerGenome and a solid relationship with the Vanderbilt team. If your institution has its own rules, those can easily be added too.
Feel free to message me -- I'm happy to talk further. -
WuXi NextCODE support somatic cancer
Hi Gerald, I am with WuXi NextCODE. We do support somatic cancer. If you want a demo, please let me know. I am happy to walk you through it.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment